Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039726 | SCV000063415 | benign | not specified | 2015-07-21 | criteria provided, single submitter | clinical testing | p.Val115Met in exon 5 of PCDH15: This variant is not expected to have clinical s ignificance because it has been identified in 0.6% (60/10352) of African chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org, dbSNP rs143570915). |
Eurofins Ntd Llc |
RCV000039726 | SCV000343796 | likely benign | not specified | 2016-08-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000839729 | SCV000981633 | likely benign | not provided | 2018-03-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000839729 | SCV001024301 | likely benign | not provided | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002513555 | SCV003658832 | uncertain significance | Inborn genetic diseases | 2022-11-10 | criteria provided, single submitter | clinical testing | The c.343G>A (p.V115M) alteration is located in exon 5 (coding exon 4) of the PCDH15 gene. This alteration results from a G to A substitution at nucleotide position 343, causing the valine (V) at amino acid position 115 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004534842 | SCV004743777 | likely benign | PCDH15-related disorder | 2020-02-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |